American Century Companies’s Stoke Therapeutics STOK Stock Holding History

American Century Companies's STOK Position: Q1 2026 in Review

American Century Companies reduced its Stoke Therapeutics (STOK) stake by 80% in Q1 2026, selling an estimated $3.01M and leaving 23,397 shares worth $762K. The position accounts for ﹤0.01% of the portfolio, ranked #2408.

American Century Companies first reported a position in STOK in Q2 2019 and has held it in 11 quarters since. The position peaked at $4.06M in Q4 2019. 196 funds tracked by Wall St. Rank hold STOK as of Q1 2026.

• American Century Companies held 23,397 shares of Stoke Therapeutics worth $762K as of Q1 2026.
• American Century Companies sold 91,721 Stoke Therapeutics shares in Q1 2026, an estimated $3.01M.
• Stoke Therapeutics made up ﹤0.01% of American Century Companies's portfolio in Q1 2026, its #2408 holding.
• American Century Companies first reported a position in Stoke Therapeutics in Q2 2019 and has held it in 11 quarters since.
• American Century Companies's Stoke Therapeutics position peaked at $4.06M in Q4 2019.
• 196 funds tracked by Wall St. Rank held Stoke Therapeutics as of Q1 2026.

Based on American Century Companies's 13F filing for Q1 2026, filed 15 May 2026.